SUMMARYWhat is known and objective: Hyponatraemia, the most common electrolyte imbalance occurring in hospitalized subjects, is usually classified as hypovolaemic, euvolaemic or hypervolaemic. Hyponatraemia is a predictor of death among subjects with chronic heart failure and cirrhosis. The inappropriate secretion of the antidiuretic hormone (AVP) seems to be of pivotal importance in the decline of serum sodium concentration in these clinical conditions. The objective of this review was to summarize recent progress in management of hyponatraemia in SIADH, cirrhosis and heart failure. Methods: Literature searches were conducted on the topics of hyponatraemia and vasopressin receptor antagonists, using PubMed, pharmaceutical company websites and news reports. The information was evaluated for relevance and quality, critically assessed and summarized. Results and discussion: The initial treatment of severe hyponatraemia is directed towards the prevention or management of neurological manifestations and consists of an intravenous infusion of hypertonic saline. Fluid restriction is indicated in oedematous states. Diuretics alone or in combination with other specific drugs remain the main strategy in the management of volume overload in heart failure. In resistant cases, ultrafiltration can lead to effective removal of isotonic fluid preventing new episodes of decompensation; however, aquapheresis is associated with increased costs and other limits. In several trials, the efficacy of vasopressin receptor antagonists in euvolaemic patients (inappropriate antidiuretic hormone secretion) or in hypervolaemic hyponatraemia (chronic heart failure, cirrhosis) has been evaluated. It was found that vaptans, which promote aquaresis, were superior to a placebo in raising and maintaining serum sodium concentrations in these subjects. What is new and conclusions: Combined with conventional therapy, vasopressin receptor antagonists (AVP-R antagonists) are able to increase the excretion of electrolyte-free water and the sodium concentration. Further studies are needed to assess efficacious outcomes of aquaresis compared with aquapheresis and with conventional therapy.
WHAT IS KNOWN AND OBJECTIVEHyponatraemia is variably defined, but a serum sodium concentration below 135 mEq/L is the cut-off most frequently used.1 It is the most common electrolyte imbalance present in hospitalized subjects, with an incidence of 15-22% for values of serum sodium <135 mEq/L and of 1-4% for values <130 mEq/L.2,3 Hyponatraemia is associated with increased morbidity and mortality among subjects with heart, liver or neurologic disease.
4-7The prevalence of hyponatraemia varies widely depending on the clinical setting. The highest frequencies are observed in intensive care units (ICU), in the post-operative setting and in older subjects admitted to geriatric wards. In the latter, this alteration is associated with different compliances and it is due to age-related physiological changes in water and electrolyte balance, as well as in the presence of comorbi...